Hair loss company Svenson has introduced a new hair loss product to the Asian market that they claim can treat excess shedding by means of a unique stem extract serum. The Svenson website claims that the extract is: “Formulated with a blend of powerful and effective ingredients that target beyond the roots of your hair problems.”
The website goes on to explains that the system works by “using Nano Encapsulation technology,” where apparently the “stem extract formula reaches deep into the scalp allowing for a slow-release effect”. The result is allegedly “fuller-looking hair,” and the treatment also claims to promote “vital nourishment to hair follicles for “healthier and thick looking hair”.
Big Claims, Where’s The Evidence?
Michael Bernstein, chief trichologist of USA Svenson, said StemPlus was “a result of scientific stem-cell research” that has been “acclaimed by leading trichologists in the US and Europe.”
There has long been discussion of stem cells for hair loss treatment, however Svenson is yet to publish any conclusive study results that prove the effectiveness of their latest offering, and no significant medical body such as the FDA, has licensed or approved the treatment, which uses stem cells from South Korea.
Mark Birch, Svenson’s British international trichologist, says that the treatment rebuilds a healthy and dense scalp through increased subcutaneous fat below the scalp whilst providing anti-microbial benefits, healing any inflammation.
There have been several studies with regards to using stem cells as part of a hair loss treatment, from generating hair on mice with stem cells, to the so called ‘vampire bat treatment‘ that involves re-injecting people with their own stem cells. However, medical bodies are yet to approve any form of stem cell treatment for male pattern hair loss, and whilst studies provide interesting data and prove the need for further research, a definitive case for stem cell treatment for male pattern hair loss is yet to be made.
The Proven Treatment
For those wishing to address their hair loss, the MHRA and the FDA (the UK and US medical regulatory bodies) have licensed or approved just two medications, which are highly complementary. The first of these, Propecia, works by blocking DHT, the androgen hormone that damages hair follicles atop the scalp, causing them to shrink and produce thinner hair.
The second proven medication, minoxidil, is a topical treatment that stimulates new hair growth. Belgravia produce minoxidil in a variety of strengths, and a hair loss specialist can create a bespoke treatment plan around your exact needs, potentially including a high strength minoxidil cream for particularly stubborn thinning.
Treatment plans also contain a range of hair growth boosters, such as the FDA cleared LaserComb, which can speed up regrowth in some cases. Regular check-ups are also important as they allow a specialist to measure your progress and adapt your treatment if necessary.
The Belgravia Centre—————————————————————————————————–
The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. We offer clinically proven treatments for hair loss, as part of comprehensive treatment programmes offered by our hair loss specialists. Our in-house pharmacies produce high-strength medications for hair loss that contain medically proven ingredients and are available at no other clinic worldwide. Treatment programmes are available by visiting the centres or for home-use, anywhere in the UK or the rest of the world. View our hair loss success stories, which are the largest collection of such success stories in the world and demonstrate the levels of hair regrowth that so many of Belgravia’s patients achieve. You can also phone 0800 077 6666 for our hair loss helpline or to arrange a free consultation.This entry was posted on Friday, August 9th, 2013 at 1:22 pm and is filed under General Hair Loss, Hair Loss, Hair Loss News, Male Hair Loss. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.